EQT also remains a bidder but the Swedish buy-out firm's chances are seen as slim because it stands to gain fewer synergies from the deal and has less financial fire power than its rivals from the healthcare industry, the newspaper cited financial sources as saying.
More at Reuters
1 comment:
My idea is either a new drug for treating chronic pain or addicts will thank me.. only time will tell.
Designing Opioid-TRIs for Chronic Pain.
http://pharmaheretic.wordpress.com/2010/01/18/designing-opioid-tris-for-pain/
Post a Comment